Human liver microbiota modeling strategy at the early onset of fibrosis

HIGHLIGHTS

• who: Camille Champion from the A multicentric observational study was conducted in the Second Department of Surgery, Emergency Mureu015f County Hospital of Romania, the Department of Systems Medicine of the Tor Vergata University of Rome, the Institut d`Investigacio Biomedica de Girona IdibGi, the Endocrinology and Nutrition Department of DrJosep Trueta University Hospital, and the University Hospital of Innsbruck. Exclusion criteria were serious liver diseases (eg hemochromatosis, alcoholic fatty liver disease, Hepatitis B and Hepatitis C infection, chronic diseases, inflammatory systemic diseases, acute or chronic infections in the previous month, use of antibiotic, antifungal, antiviral drugs, proton . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.